Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corp (NQ: CERS )

4.780 -0.340 (-6.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,382,205
Open 5.010
Bid (Size) 3.010 (1)
Ask (Size) 4.780 (3)
Prev. Close 5.120
Today's Range 4.760 - 5.060
52wk Range 4.380 - 8.055
Shares Outstanding 173,721,524
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets
From Cerus Corporation
Via Business Wire

Performance

YTD
-31.62%
-31.62%
1 Month
+2.80%
+2.80%
3 Month
-13.25%
-13.25%
6 Month
-34.07%
-34.07%
1 Year
-17.37%
-17.37%

More News

Read More
Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
From Cerus Corporation
Via Business Wire
Recap: Cerus Q4 Earnings
Via Benzinga
Earnings Scheduled For February 22, 2022
Via Benzinga
Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference
From Cerus Corporation
Via Business Wire
Cerus's Return On Capital Employed Overview
Via Benzinga
Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales
Via Benzinga
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
From Cerus Corporation
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Uncertain Times
Via Talk Markets
Cerus Corporation to Participate in Stephens Annual Investment Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
From Cerus Corporation
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
86 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Via Benzinga
Topics Retirement
Exposures Pension
Cerus Posts Lower Than Expected Q3 Loss; Raises FY21 Sales Guidance
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.